Pulmonary perfusion with oxygenated blood or custodiol HTK solution during cardiac surgery for postoperative pulmonary function in COPD patients: a trial protocol for the randomized, clinical, parallel group, assessor and data analyst blinded Pulmonary Protection Trial

BACKGROUND: Five to thirty percent of patients undergoing cardiac surgery present with chronic obstructive pulmonary disease (COPD) and have a 2- to 10-fold higher 30-day mortality risk. Cardiopulmonary bypass (CPB) creates a whole body systemic inflammatory response syndrome (SIRS) that could impai...

Descripción completa

Detalles Bibliográficos
Autores principales: Buggeskov, Katrine B, Wetterslev, Jørn, Secher, Niels H, Andersen, Lars W, Jonassen, Thomas, Steinbrüchel, Daniel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576307/
https://www.ncbi.nlm.nih.gov/pubmed/23363494
http://dx.doi.org/10.1186/1745-6215-14-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576307/
https://www.ncbi.nlm.nih.gov/pubmed/23363494
http://dx.doi.org/10.1186/1745-6215-14-30

Ejemplares similares